TY  - GEN
AU  - Dibenedetto,S P
AU  - Lo Nigro,L
AU  - Mayer,S P
AU  - Rovera,G
AU  - Schilirò,G
TI  - Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia
SN  - 0006-4971
PY  - 1997///0825
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Asparaginase
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Blotting, Southern
KW  - methods
KW  - Bone Marrow
KW  - pathology
KW  - Child
KW  - Child, Preschool
KW  - Cohort Studies
KW  - Cyclophosphamide
KW  - Cytarabine
KW  - DNA, Neoplasm
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Evaluation Studies as Topic
KW  - Female
KW  - Fluorometry
KW  - Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
KW  - Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
KW  - Humans
KW  - Immunophenotyping
KW  - Infant
KW  - Italy
KW  - epidemiology
KW  - Leucovorin
KW  - Leukemia-Lymphoma, Adult T-Cell
KW  - drug therapy
KW  - Male
KW  - Mercaptopurine
KW  - Methotrexate
KW  - Neoplasm, Residual
KW  - Neoplastic Stem Cells
KW  - chemistry
KW  - Nucleic Acid Hybridization
KW  - Polymerase Chain Reaction
KW  - Prednisone
KW  - Prognosis
KW  - Prospective Studies
KW  - Receptors, Antigen, T-Cell, gamma-delta
KW  - Remission Induction
KW  - Sensitivity and Specificity
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -